Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs).

Front Oncol · 2020 · PMC7324627 · PMID 32656072

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

marginal significanceP < 0.001actually significant

When stratified by the region, there was a marginal significance between high pretreatment NLR and worse OS in the region of Asia (HR = 4.05, 95% CI 2.25–7.31; P < 0.001) and the regions of Europe and America (HR = 2.67, 95% CI 1.88–3.79, P < 0.001).

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.